AFS Financial Group’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-6,016
Closed -$349K 63
2023
Q3
$349K Buy
6,016
+300
+5% +$18.4K 0.24% 65
2023
Q2
$366K Hold
5,716
0.24% 66
2023
Q1
$396K Sell
5,716
-100
-2% -$7.05K 0.26% 62
2022
Q4
$418K Buy
+5,816
New +$439K 0.3% 57

Other funds holding BMY

AFS Financial Group's BMY Position: Q4 2023 in Review

AFS Financial Group sold out of Bristol-Myers Squibb (BMY) in Q4 2023, closing a stake of 6,016 shares — an estimated $349K sold.

AFS Financial Group first reported a position in BMY in Q4 2022 and held it in 4 quarters. The position peaked at $418K in Q4 2022. 2,363 funds tracked by Wall St. Rank hold BMY as of Q4 2023.

  • AFS Financial Group reported no remaining Bristol-Myers Squibb position as of Q4 2023 after selling out during the quarter.
  • AFS Financial Group sold 6,016 Bristol-Myers Squibb shares in Q4 2023, an estimated $349K.
  • AFS Financial Group first reported a position in Bristol-Myers Squibb in Q4 2022 and held it in 4 quarters.
  • AFS Financial Group's Bristol-Myers Squibb position peaked at $418K in Q4 2022.
  • 2,363 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2023.

Based on AFS Financial Group's 13F filing for Q4 2023, filed 23 Jan 2024.